Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: Relationship with the response to interferon treatment

Journal of Hepatology

Volumn 25, Issue 1, 1996, Pages 1-9

  Sarobe, Pablo ^a   Jauregui, Javier Ignacio ^a   Lasarte, Juan José ^a   García, Nicolás ^a   Civeira, María Pilar ^a   Borrás Cuesta, Francisco ^a   Prieto, Jesús ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Alpha interferon; Cellular immune response; Hepatitis C virus; Interleukin 2; Synthetic peptides

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HUMAN; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030198601     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80320-5     Document Type: Article

References (24)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Dienstag JL. Non-A, Non-B hepatitis. Recognition, epidemiology and clinical features. Gastroenterology. 85:1983;439-462.
3. Camps J, Castilla A, Ruiz J, Civeira MP, Prieto J. Randomised trial of lymphoblastoid alpha-IFN in chronic hepatitis C. J Hepatol. 17:1993;390-396.
4. Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, Di Nello R, van Boven JJP, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaasberg W, Leentvaar-Kuypers A, Polito A, Houghton M, Lelie PN. Confirmation of hepatitis C virus infection by a new four-antigen recombinant immunoblot assay. Lancet. 337:1991;317-319.
5. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH. Lack of protective immunity against reinfection with hepatitis C virus. Science. 258:1992;135-140.
6. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis F, Balestrieri A, Purcell RH, Cao A, Farci P. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet. 343:1994;388-390.
7. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo Q-L, Shuster J, Kuo G, Bonino F, Houghton M, Abrignani S. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology. 104:1993;580-587.
8. Minutello MA, Pileri P, Unutmaz D, Censini F, Kuo G, Houghton M, Brunetto MR, Bonino F, Abrignani S. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med. 178:1993;17-25.
9. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F. T cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology. 19:1994;286-295.
10. Choo Q-L, Kuo G, Ralston R, Weiner A, Chien D, Van Nest, Han J, Berger K, Thudium K, Kuo C, Kansopon J, McFarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA. 91:1994;1294-1298.
11. Merrifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc. 85:1963;2149-2154.
12. Atherton E, Logan JC, Sheppard RC. Peptide synthesis. Part 2. Procedures for solid phase synthesis using N-fluorenil metoxicarbonil amino acids on polyamide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J Chem Soc Perkin Trans. 1:1981;538-546.
13. Borrás-Cuesta F, Golvano J, Sarobe P, Lasarte JJ, Prieto I, Szabo A, Guillaume JL, Guillet JG. Insights on the amino acid side-chain interactions of a synthetic T cell determinant. Biologicals. 19:1991;187-190.
14. Kaiser E, Colescott RL, Bossinger CD, Cook PI. Color test for detection of free terminal amino groups in the solid phase synthesis of peptides. Anal Biochem. 34:1970;595-598.
15. Riezu-Boj JI, Parker D, Civeira MP, Phippard D, Corbishley TP, Camps J, Castilla A, Prieto J. Detection of hepatitis C virus antibodies with new recombinant antigens: assessment in chronic liver diseases. J Hepatol. 15:1992;309-313.
16. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follet EAC, Yap PL, Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2 and 3. J Clin Microbiol. 31:1993;1493-1503.
17. Viazov S, Zibert A, Ramakrishnan K, Widell A, Cavicchini A, Schreier E, Roggendorf M. Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J Virol Methods. 48:1994;81-92.
18. Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, Tsuda F, Miyakawa Y, Mayumi M. The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med. 60:1990;167-177.
19. Imanashi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. Kimiyoshi T, Aizawa M, Sasazuki T. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. 1992;1065-1220 Oxford University Press. Vol. 1.
20. Samuel CE. Antiviral actions of IFN. Interferon regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 183:1991;1-11.
21. Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz S, Nitschko H, Riethmüller G, Pape GR. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology. 21:1995;632-638.
22. Clerici M, Stocks NI, Zajac RA, Boswell RN, Bernstein DC, Mann DL, Shearer GM, Berzofsky JA. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive patients. Nature. 339:1989;383-385.
23. Saracco G, Abate ML, Baldi M, Calvo PL, Manzini P, Brunetto MR, Oliveri F, Kuo G, Chien D, Houghton M, Verme G, Rizzetto M, Bonini F. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis. Liver. 14:1994;65-70.
24. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of IFN alpha therapy. N Engl J Med. 324:1991;933-940.